https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Diabetes-MC.jpg

Insulin Market Size, Share & Trends Analysis | Global (United States and Europe) | 2019-2025 | MedCore | Segmented by: Long-Acting Insulin, Ultra-Long-Acting Insulin, Rapid-Acting Insulin, and 2 more

  • Year: 2017
  • Scope: 2015-2025
  • Region: Europe, United States
  • Pages: 101
  • Published Date: 06/02/2019
  • Type: MedCore

The U.S. and European insulin markets include long-acting insulin, ultra-long-acting insulin, rapid-acting insulin, premixed insulin, and human insulin. Within both the U.S. and the European markets the largest segment was the long-acting insulin market, which accounted for over 37% of the total market value. The long-acting insulin market has experienced increased competition, due to the expiration of product patents and the rise of biosimilar products.

Over the forecast period, the value for both the U.S. and the European insulin markets is expected to increase over the forecast period. The U.S. market is expected to reach approximately $8 billion and the European market is expected to reach approximately €3 billion by 2025.

MARKET DATA INCLUDED

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Market Drivers & Limiters
  • Market Forecasts Until 2025, and Historical Data to 2015
  • Company Profiles and Product Portfolios
  • Leading Competitors

U.S. INSULIN MARKET INSIGHTSU.S. Insulin Market

The largest segment was the long-acting insulin market, which accounted for over 37% of the total market value. The long-acting insulin market has experienced increased competition, due to the expiration of product patents and the rise of biosimilar products. The second-largest segment was the rapid-acting insulin market. Increased adoption of insulin pump therapy will contribute to the growth of this market, as rapid-acting insulin is used for continuous subcutaneous insulin infusion (CSII). The third-largest segment was the ultra-long-acting insulin market.

EUROPE’S INSULIN MARKET INSIGHTSEurope Insulin Market

The largest segment was the long-acting insulin market. The long-acting insulin market has experienced increased competition, due to the expiration of product patents and the rise of biosimilar products. The second-largest segment was the rapid-acting insulin market. Increased adoption of insulin pump therapy will contribute to the growth of this market, as rapid-acting insulin is used for continuous subcutaneous insulin infusion (CSII). The third-largest segment was the ultra-long-acting insulin market. The ultra-long-acting insulin market has exhibited significant growth since the first product was launched in 2014.

U.S. AND EUROPEAN INSULIN MARKET SHARE INSIGHTS

Novo Nordisk, Sanofi, and Eli Lilly controlled both the U.S. and European insulin markets.U.S. and EU Insulin Market Leaders Novo Nordisk held the leading position in the ultra-long-acting insulin and rapid-acting insulin markets and the second-leading position in the long-acting insulin, premixed insulin, and human insulin markets.

REPORT REGIONAL COVERAGE

Throughout this research series, iData has covered several countries in great detail. The covered countries are:

  • North America (United States)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Benelux (Belgium, Netherlands, and Luxembourg), Scandinavia (Denmark, Finland, Norway, and Sweden), Austria, Switzerland, and Portugal)

 

FREE Sample Report

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology